Routine reduction of glaucoma medication following phacoemulsification.
Bowling
Brad
B
Calladine
Daniel
D
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D018450:Disease Progression; D017889:Exfoliation Syndrome / Q000150:complications*; D005902:Glaucoma, Open-Angle / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D006801:Humans; D007429:Intraocular Pressure; D019654:Lens Implantation, Intraocular; D018918:Phacoemulsification; D014065:Tonometry, Ocular; D014792:Visual Acuity
D000959:Antihypertensive Agents